                         SEQUENCE LISTING

<110>  THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS 
       REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND 
       HUMAN SERVICES
       THE WASHINGTON UNIVERSITY
       Isenberg, Jeffrey S
       Roberts, David D
       Frazier, William A
 
<120>  PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS

<130>  4239-75936-05

<150>  60/850,132
<151>  2006-10-06

<150>  60/864,153
<151>  2006-11-02

<150>  60/888,754
<151>  2007-02-07

<150>  60/910,549
<151>  2007-04-06

<150>  60/956,375
<151>  2007-08-16

<160>  33    

<170>  PatentIn version 3.3

<210>  1
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  1

Ile Gly Trp Lys Asp Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  2
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  2

Trp Lys Asp Phe Thr Ala Tyr Arg 
1               5               


<210>  3
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  3

Ile Gly Trp Lys Asp Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  4

Ile Gly Trp Lys Asn Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  5

Ile Gly Trp Lys Asp Phe Ala Ala Tyr Arg 
1               5                   10  


<210>  6
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  6

Ile Gly Trp Lys Asp Glu Thr Ala Tyr Arg Trp Arg Leu Ser 
1               5                   10                  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  7

His Ile Gly Trp Lys Asp Phe Thr Ala Tyr Arg Trp Arg Leu Ser 
1               5                   10                  15  


<210>  8
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  8

Lys Arg Phe Lys Gln Asp Gly Gly Trp Ser His Trp Ser Pro Trp Ser 
1               5                   10                  15      


Ser 
    


<210>  9
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  9

Val Thr Cys Gly Gly Gly Val Gln Lys Arg Ser Arg Leu 
1               5                   10              


<210>  10
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  10

Phe Ile Arg Val Val Met Tyr Glu Gly Lys Lys 
1               5                   10      


<210>  11
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  11

Phe Ile Arg Gly Gly Met Tyr Glu Gly Lys Lys 
1               5                   10      


<210>  12
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  12

Phe Ile Arg Val Ala Ile Tyr Glu Gly Lys Lys 
1               5                   10      


<210>  13
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  13

Lys Arg Phe Tyr Val Val Met Trp Lys Lys 
1               5                   10  


<210>  14
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  14

Arg Phe Tyr Val Val Met Trp Lys 
1               5               


<210>  15
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  15

Arg Phe Tyr Gly Gly Met Trp Lys 
1               5               


<210>  16
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  16

Ile Gly Trp Lys Ala Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  17
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  17

Arg Lys Arg Ser Arg Ala Glu 
1               5           


<210>  18
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  18

Val Thr Ala Gly Gly Gly Val Gln Lys Arg Ser Arg Leu 
1               5                   10              


<210>  19
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  19

Gly Asp Gly Val Asp Ile Thr Arg Ile Arg 
1               5                   10  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  20

Ile Gly Trp Lys Asp Tyr Thr Ala Tyr Arg 
1               5                   10  


<210>  21
<211>  25
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oliogonucleotide

<400>  21
cgtcacaggc aggacccact gccca                                           25


<210>  22
<211>  25
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oliogonucleotide

<400>  22
cgtgacagcc acgaccgact gcgca                                           25


<210>  23
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oliogonucleotide

<400>  23
ctgctccaga cacctgagg                                                  19


<210>  24
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oliogonucleotide

<400>  24
cgtcttagta ctctccaatc                                                 20


<210>  25
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  25

Ile Gly Trp Lys Gly Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  26
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  26

Gly Ala Lys Asp Phe Thr Ala Tyr Arg 
1               5                   


<210>  27
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  27

Ile Gly Trp Lys Asp Phe Thr Ala Ala Arg 
1               5                   10  


<210>  28
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  28

Ile Gly Trp Lys Asp Phe Thr Ala Tyr Lys 
1               5                   10  


<210>  29
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  29

Ile Gly Trp Ala Asp Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  30
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  30

Ile Gly Trp His Asp Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  31
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  31

Ile Gly Trp Lys Glu Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  32
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  32

Ala Gly Trp Lys Asp Phe Thr Ala Tyr Arg 
1               5                   10  


<210>  33
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  33

Ile Gly Tyr Lys Asp Phe Thr Ala Tyr Arg 
1               5                   10  


